Issue 21, 2008

A rational design by hydrothermal methods of a tetrazolate-bridged bimetallic spin-canted antiferromagnet. Synthesis, X-ray structure and magnetic properties of [CoNi(pmtz)4] (Hpmtz = 5-(pyrimidyl)tetrazole)

Abstract

The bimetallic complex [CoNi(pmzt)4] (pmtz = 5-(pyrimidyl)tetrazolate ligand) has been prepared by hydrothermal treatment of an equimolecular mixture of the mononuclear complexes[Co(pmtz)2(H2O)2] and [Ni(pmtz)2(H2O)2]. The structure of [CoNi(pmzt)4] consists of (4,4) square-grid-like sheets, in which Co(II) and Ni(II) metal ions are connected by pmtz bridging ligands. This compound is a spin-canted antiferromagnet (weak ferromagnet) with Tc = 18 K. Although Co(II) and Ni(II) ions have different spin values, the spin-canted structure can be formed because of the accidental compensation of their magnetic moments. Both magnetic anisotropy and antisymmetric exchange interaction promote the spin canting of the compensated magnetic moments in the 3D antiferromagnetic phase. On passing from the homometallic complex, [Co2(pmzt)4], which is also a spin-canted antiferromagnet with Tc = 15 K, to the bimetallic complex, [CoNi(pmzt)4], Tc increases and the hysteresis parameters, remnant magnetization (Mr) and critical field (Hc), decrease. The increase in Tc may be a consequence of the increase of the JCoNi, whereas the decrease in Mr and Hc is probably due to the presence in [CoNi(pmzt)4] of a lower content of the highly anisotropic Co(II) ion

Graphical abstract: A rational design by hydrothermal methods of a tetrazolate-bridged bimetallic spin-canted antiferromagnet. Synthesis, X-ray structure and magnetic properties of [CoNi(pmtz)4] (Hpmtz− = 5-(pyrimidyl)tetrazole)

Supplementary files

Article information

Article type
Paper
Submitted
23 Jan 2008
Accepted
14 Mar 2008
First published
21 Apr 2008

Dalton Trans., 2008, 2887-2893

A rational design by hydrothermal methods of a tetrazolate-bridged bimetallic spin-canted antiferromagnet. Synthesis, X-ray structure and magnetic properties of [CoNi(pmtz)4] (Hpmtz = 5-(pyrimidyl)tetrazole)

A. Rodríguez-Diéguez, M. A. Palacios, A. Sironi and E. Colacio, Dalton Trans., 2008, 2887 DOI: 10.1039/B801306C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements